Senseonics Holdings Inc SENS
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2015-03-04 |
| Shares Out. | 41,800,000 |
| Website | senseonics.com/ ↗ |
| Phone | 13015157260 |
| Employees | 130 |
| Revenue | $11.7M |
| Gross Profit | $6.9M |
| Net Income | -$32.3M |
| Free Cash Flow | -$75.9M |
| Total Assets | $102.9M |
| Total Liabilities | $68.5M |
| Equity | $34.3M |
About Senseonics Holdings Inc
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Senseonics Holdings Inc is a publicly traded company under the ticker symbol SENS on the NYSE MKT LLC, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-07-01)